Please disable your adblock and script blockers to view this page

Medicare to Pay for Biogen?s New Alzheimer?s Drug in Clinical-Trial Patients


MembershipCustomer ServiceTools & FeaturesAdsMoreDow Jones Products

No matching tags

No matching tags

No matching tags

No matching tags

No matching tags

No matching tags

Positivity     14.00%   
   Negativity   86.00%
The New York Times
SOURCE: https://www.wsj.com/articles/medicare-to-pay-for-biogens-new-alzheimers-drug-in-clinical-trial-patients-11641937588?mod=hp_lead_pos4
Write a review: The Wall Street Journal
Summary

The Centers for Medicare and Medicaid Services said it will cover the cost of the drug Aduhelm, but as part of further clinical testing

As said here by Joseph Walker